Life sciences firm Danaher to buy Abcam in $5.7 billion deal
By Manas Mishra (Reuters) – Danaher Corp on Monday agreed to buy protein consumables manufacturer Abcam Plc in a $5.7 billion all-cash deal including debt, as the medical tools supplier looks to expand its portfolio of products and services. The deal will help Danaher cushion the hit from sluggish demand for some of its products …
Life sciences firm Danaher to buy Abcam in $5.7 billion deal Read More »









